Mannkind (MNKD) Net Margin Growth (3y) (2019 - 2026)

Mannkind (MNKD) Net Margin Growth (3y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,283.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -569.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 6,537.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn 568.00

Historic Data

Download Data
DateValue
Mar 31, 2026 568.00
Dec 31, 2025 3,553.00
Sep 30, 2025 5,368.00
Jun 30, 2025 15,445.00
Mar 31, 2025 23,359.00
Dec 31, 2024 23,388.00
Sep 30, 2024 3,641.00
Jun 30, 2024 14,981.00
Mar 31, 2024 9,012.00
Dec 31, 2023 14,561.00
Sep 30, 2023 8,029.00
Jun 30, 2023 511,517.00
Mar 31, 2023 3,331.00
Dec 31, 2022 -27,975.00
Sep 30, 2022 143,746.00
Jun 30, 2022 603,989.00
Mar 31, 2022 -13,150.00
Dec 31, 2021 -17,916.00
Sep 30, 2021 52,087.00
Jun 30, 2021 42,987.00